First Time Loading...
S

StemRIM Inc
TSE:4599

Watchlist Manager
StemRIM Inc
TSE:4599
Watchlist
Price: 443 JPY -1.12%
Updated: Apr 23, 2024

Intrinsic Value

StemRIM, Inc. engages in the research and development of regeneration inducing medicine. [ Read More ]

The intrinsic value of one StemRIM Inc stock under the Base Case scenario is 127.44 JPY. Compared to the current market price of 443 JPY, StemRIM Inc is Overvalued by 71%.

Key Points:
Intrinsic Value
Base Case
127.44 JPY
Overvaluation 71%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
StemRIM Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling StemRIM Inc stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
StemRIM Inc

Provide an overview of the primary business activities
of StemRIM Inc.

What unique competitive advantages
does StemRIM Inc hold over its rivals?

What risks and challenges
does StemRIM Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for StemRIM Inc.

Provide P/S
for StemRIM Inc.

Provide P/E
for StemRIM Inc.

Provide P/OCF
for StemRIM Inc.

Provide P/FCFE
for StemRIM Inc.

Provide P/B
for StemRIM Inc.

Provide EV/S
for StemRIM Inc.

Provide EV/GP
for StemRIM Inc.

Provide EV/EBITDA
for StemRIM Inc.

Provide EV/EBIT
for StemRIM Inc.

Provide EV/OCF
for StemRIM Inc.

Provide EV/FCFF
for StemRIM Inc.

Provide EV/IC
for StemRIM Inc.

Show me price targets
for StemRIM Inc made by professional analysts.

What are the Revenue projections
for StemRIM Inc?

How accurate were the past Revenue estimates
for StemRIM Inc?

What are the Net Income projections
for StemRIM Inc?

How accurate were the past Net Income estimates
for StemRIM Inc?

What are the EPS projections
for StemRIM Inc?

How accurate were the past EPS estimates
for StemRIM Inc?

What are the EBIT projections
for StemRIM Inc?

How accurate were the past EBIT estimates
for StemRIM Inc?

Compare the revenue forecasts
for StemRIM Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of StemRIM Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of StemRIM Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of StemRIM Inc compared to its peers.

Compare the P/E ratios
of StemRIM Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing StemRIM Inc with its peers.

Analyze the financial leverage
of StemRIM Inc compared to its main competitors.

Show all profitability ratios
for StemRIM Inc.

Provide ROE
for StemRIM Inc.

Provide ROA
for StemRIM Inc.

Provide ROIC
for StemRIM Inc.

Provide ROCE
for StemRIM Inc.

Provide Gross Margin
for StemRIM Inc.

Provide Operating Margin
for StemRIM Inc.

Provide Net Margin
for StemRIM Inc.

Provide FCF Margin
for StemRIM Inc.

Show all solvency ratios
for StemRIM Inc.

Provide D/E Ratio
for StemRIM Inc.

Provide D/A Ratio
for StemRIM Inc.

Provide Interest Coverage Ratio
for StemRIM Inc.

Provide Altman Z-Score Ratio
for StemRIM Inc.

Provide Quick Ratio
for StemRIM Inc.

Provide Current Ratio
for StemRIM Inc.

Provide Cash Ratio
for StemRIM Inc.

What is the historical Revenue growth
over the last 5 years for StemRIM Inc?

What is the historical Net Income growth
over the last 5 years for StemRIM Inc?

What is the current Free Cash Flow
of StemRIM Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for StemRIM Inc.

Financials

Balance Sheet Decomposition
StemRIM Inc

Current Assets 9.8B
Cash & Short-Term Investments 9.2B
Other Current Assets 643.8m
Non-Current Assets 232.5m
PP&E 205.3m
Intangibles 2.9m
Other Non-Current Assets 24.3m
Current Liabilities 124.1m
Accrued Liabilities 23.4m
Other Current Liabilities 100.8m
Non-Current Liabilities 118.6m
Other Non-Current Liabilities 118.6m
Efficiency

Earnings Waterfall
StemRIM Inc

Revenue
2.4B JPY
Operating Expenses
-2.2B JPY
Operating Income
150.8m JPY
Other Expenses
28.6m JPY
Net Income
179.4m JPY

Free Cash Flow Analysis
StemRIM Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

StemRIM Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Positive ROIC
ROE is Increasing
Positive 3-Years Revenue Growth
Declining ROIC
25/100
Profitability
Score

StemRIM Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

StemRIM Inc's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
93/100
Solvency
Score

StemRIM Inc's solvency score is 93/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
StemRIM Inc

Wall Street analysts forecast StemRIM Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for StemRIM Inc is 918 JPY with a low forecast of 909 JPY and a high forecast of 945 JPY.

Lowest
Price Target
909 JPY
105% Upside
Average
Price Target
918 JPY
107% Upside
Highest
Price Target
945 JPY
113% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
StemRIM Inc

1M 1M
-12%
6M 6M
-30%
1Y 1Y
-65%
3Y 3Y
-41%
5Y 5Y
-53%
10Y 10Y
-53%
Annual Price Range
443
52w Low
422
52w High
1 300
Price Metrics
Average Annual Return 0.4%
Standard Deviation of Annual Returns 27.79%
Max Drawdown -73%
Shares Statistics
Market Capitalization 27.2B JPY
Shares Outstanding 61 469 700
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

StemRIM Inc

Country

Japan

Industry

Biotechnology

Market Cap

27.2B JPY

Dividend Yield

0%

Description

StemRIM, Inc. engages in the research and development of regeneration inducing medicine. The company is headquartered in Ibaraki-Shi, Osaka-Fu and currently employs 46 full-time employees. The company went IPO on 2019-08-09. The firm is engaged in the development and research of medicines based on new action mechanism to promote functional regeneration and healing of biological tissue damaged and lost function due to injury or illness. The Company’s main product is stem cell regeneration-inducing medicine. The stem cell regeneration-inducing medicine is a medicine which can obtain the same therapeutic effect as regenerative medicine only by administering the medicine without using living cells and tissues.

Contact

OSAKA-FU
Ibaraki-shi
3F, Saito Bio-Incubator, 7-7-15, Saito Asagi
+81726487152.0
https://stemrim.com/

IPO

2019-08-09

Employees

46

Officers

Executive Chairman
Mr. Kensuke Tomita
President, CEO & Representative Director
Mr. Masatsune Okajima
Chief Scientific Officer, Director of Basic Research Department & Director
Mr. Katsuto Tamai
Head of Drug Discovery, Basic Research, R&D and Intellectual Prop., Dept. and Executive Officer
Mr. Takehiko Yamazaki

See Also

Discover More
What is the Intrinsic Value of one StemRIM Inc stock?

The intrinsic value of one StemRIM Inc stock under the Base Case scenario is 127.44 JPY.

Is StemRIM Inc stock undervalued or overvalued?

Compared to the current market price of 443 JPY, StemRIM Inc is Overvalued by 71%.